Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

CAR-T Based Immunotherapy for B-Cell Non-Hodgkin Lymphoma

A Phase I Single Arm, Open-Label Study to Evaluate the Safety of UF-KURE19 Cells in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

physician hugging cancer patient


AGE: >18 years old
CONDITION: Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NHL)
TYPE: Interventional Treatment Study

Learn More About This Research Study

Please call 1-800-641-2422 for more information or complete the online form below.

Study Purpose

The purpose of this study is to determine if it is possible to treat your cancer with a new type of T-cell based immunotherapy, therapy that uses your immune system to treat the cancer.

Who Can Participate

Participants 18 years and older who have been diagnosed with relapsed or refractory non-Hodgkin lymphoma treated may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot